relevance: rituximab and lenalidomide in fl
Published 2 years ago • 566 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:10
the relevance study: lenalidomide plus rituximab vs. rituximab-chemotherapy in the treatment of fl
-
0:39
10 year follow up of rituximab and lenalidomide in low tumor burden fl
-
3:52
results of relevance: frontline rituximab-lenalidomide for follicular lymphoma
-
2:22
phase ib trial of acalabrutinib rituximab with or without lenalidomide in r/r follicular lymphoma
-
1:30
polatuzumab vedotin plus rituximab and lenalidomide in dlbcl: a phase ib/ii study
-
10:31
rituximab infusion | what i packed what went down!
-
57:50
what is it like to have chemotherapy webinar video april 2023
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:20
tazemetostat lenalidomide & rituximab vs. lenalidomide & rituximab in patients with r/r fl
-
7:45
epcore nhl-2: epcoritamab with rituximab and lenalidomide in newly diagnosed and r/r fl
-
1:38
management of fl relapsed or progressed after frontline lenalidomide and rituximab
-
1:48
tazemetostat in combination with lenalidomide and rituximab for r/r follicular lymphoma
-
6:54
lenalidomide rituximab in mcl: 7-year follow-up analysis
-
5:12
phase ii trial of acalabrutinib, lenalidomide and rituximab in patients with mcl
-
2:50
venetoclax, lenalidomide rituximab: a chemotherapy-free regimen for previously untreated mcl
-
3:21
relevance study: the r-squared regimen for follicular lymphoma
-
1:28
a long-term analysis of lenalidomide and rituximab for the treatment of cll
-
1:53
relapsed follicular lymphoma: hope from a non-chemotherapy regimen of lenalidomide and obinutuzumab
-
2:05
augment-ing treatment: lenalidomide plus rituximab for r/r indolent nhl
-
2:29
evaluating the combination of nivolumab and lenalidomide in relapsed hl and lbcl
-
1:23
r2 in the second-line: lenalidomide-rituximab improves pfs in relapsed/refractory nhl
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma